SMS Pharmaceuticals will continue its Unit 2 operations located at Hyderabad without any interruption in manufacturing. This is pursuant to the order issued by the Appellate Authority vide its order dated July 21, 2012 in the hearings held on July 18, July 19 and July 21, 2012.
Earlier, the company had received a closure order from the Andhra Pradesh Pollution Control Board (APPCB), Hyderabad vide its order dated July 10, 2012 alleging manufacturing new products and exceeding consented capacities. The APPCB had asked to stop the operations pertaining to the company's Unit -II located at Plot No.24 & 24B, S.V. Co-operative Industrial Estate, Batchupally, Andhra Pradesh with effect from July 23, 2012.
SMS Pharmaceuticals is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates. The company has six manufacturing facilities and two R&D facilities located in Andhra Pradesh.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: